Clinical Trial Update: Trial Involving Subjects Over 70 Years of Age With Non Small-cell Lung Cancer of Stage IV and Comparing a "Classical" Strategy of Treatment Allocation, With an"Optimized" Strategy Allocating the Same Treatments [Phase 3]

View source ↗

Summary

Phase 3 trial comparing a 'classical' treatment allocation strategy versus an 'optimized' strategy for subjects with advanced non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Rennes University Hospital | Conditions: Non Small-cell Lung Cancer | Phase 3 | Status: COMPLETED